GOSS
Gossamer Bio Inc
10.90$
+0.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | -90.1% | -1.1% | +5.4% | +16.2% | +15.7% | +3.8% | +22.9% | -45.5% | – | |
| – | -8.6% | -2.0% | +0.6% | – | – | – | – | – | – | +2.2% | – | – | |
| – | – | -117.1% | – | -90.1% | -1.1% | +5.4% | +16.2% | +15.7% | +3.8% | +21.2% | -44.8% | – | |
| – | -3.9% | +8.1% | +8.3% | -0.5% | +3.5% | +5.3% | +9.3% | +27.5% | -7.7% | -12.0% | -38.7% | – | |
| – | -2.5% | +5.6% | -9.4% | -1.9% | +10.5% | -7.8% | +0.2% | +8.2% | +16.1% | +71.9% | -52.5% | – | |
| – | +21.1% | -14.4% | +4.3% | -0.8% | +4.9% | +2.6% | +7.6% | +24.2% | -4.1% | +2.9% | -42.7% | – | |
| – | – | – | – | -165.1% | – | – | – | – | – | – | – | – | |
| – | -3.1% | -3.4% | -6.8% | -6.2% | +0.1% | +0.3% | -0.1% | +0.1% | +0.1% | +0.1% | -1.8% | – | |
| – | – | – | – | -159.5% | – | – | – | – | – | – | – | – | |
| – | -417.2% | – | – | -125.5% | – | – | – | – | – | – | – | – | |
| – | – | – | – | -162.6% | – | – | – | – | – | – | – | – | |
| – | – | – | – | -148.8% | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.